AstraZeneca has made a non-binding offer of about $10 billion for Rhythm Pharmaceuticals, Reuters reports. Rhythm’s latest results show the attraction of its rare-obesity franchise, but milestone payments complicate the headline price.
Enhanced convenience and nationwide fulfillment support SenesTech’s growing ecommerce business SURPRISE, Ariz., Nov. 03, 2026 (GLOBE NEWSWIRE) — SenesTech, Inc. (NASDAQ: SNES), an innovator in rodent birth control, today announced that its
Index rises to 146 as sales increase +2.3% year over year and +0.3% month over month MILWAUKEE, Nov. 03, 2026 (GLOBE NEWSWIRE) — Fiserv, Inc. (NASDAQ: FISV), a leading global provider of
Brand-new product line up, 11:30AM Press Conference, visitor giveaways, Fat Fender Garage F-100 and TJ Hunt Aston Martin Vantage GT3 among highlights of Meguiar’s SEMA 2026 Booth # 22357 in Central Hall
MIDLAND, Texas, Nov. 03, 2026 (GLOBE NEWSWIRE) — New Era Energy & Digital, Inc. (Nasdaq: NUAI) (“New Era” or the “Company”), a developer of next-generation digital infrastructure and integrated power assets, today
MCLEAN, Va., Nov. 03, 2026 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today posted its 2027 funding calendar, which provides optional announcement dates for Reference Notes® securities and announcement dates for Reference
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today
Seasoned biopharmaceutical executive with more than 30 years of leadership experience spanning clinical development, regulatory strategy and operational execution appointed to lead company into new phase of clinical development and growth NEW
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that
ALACHUA, Fla. and TAMPA, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) — Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function,
Follow